{"id":7119,"date":"2021-03-16T09:45:00","date_gmt":"2021-03-16T08:45:00","guid":{"rendered":"https:\/\/forum.schreiner-group.com\/?p=7119"},"modified":"2022-11-29T17:35:17","modified_gmt":"2022-11-29T16:35:17","slug":"medication-adherence-digital-therapy-management-for-clinical-trials","status":"publish","type":"post","link":"https:\/\/forum.schreiner-group.com\/en\/medication-adherence-digital-therapy-management-for-clinical-trials\/","title":{"rendered":"Medication Adherence: Digital Therapy Management for Clinical Trials"},"content":{"rendered":"<section class=\"wpb-content-wrapper\"><p>[vc_row full_width=&#8221;stretch_row_content_no_spaces&#8221; content_placement=&#8221;top&#8221; css=&#8221;.vc_custom_1614180144117{margin-top: 150px !important;}&#8221; parallax_background_image=&#8221;7116&#8243;][vc_column][vc_empty_space height=&#8221;615px&#8221;][\/vc_column][\/vc_row][vc_row css=&#8221;.vc_custom_1596612545427{background-color: #ffffff !important;}&#8221; el_class=&#8221;article_bighead&#8221;][vc_column][vc_custom_heading text=&#8221;SCHREINER MEDIPHARM&#8221; font_container=&#8221;tag:h2|text_align:center&#8221; use_theme_fonts=&#8221;yes&#8221; el_class=&#8221;topcategory&#8221;][vc_custom_heading text=&#8221;Medication Adherence: Digital Therapy Management for Clinical Trials&#8221; font_container=&#8221;tag:h1|text_align:center&#8221; use_theme_fonts=&#8221;yes&#8221;][\/vc_column][\/vc_row][vc_row css=&#8221;.vc_custom_1594633744978{padding-bottom: 3% !important;}&#8221;][vc_column][vc_column_text]<strong>Lack of knowledge, fear of side effects or forgetfulness: 50 percent of patients involved in clinical trials do not adhere to the prescribed dosage regimen. At the same time, pharmaceutical companies depend on strict compliance with therapy regimes. Otherwise trials may produce distorted outcomes such as insufficient drug efficacy or underestimated frequency of side effects, ultimately resulting in delayed time to market. The Medication Adherence Monitoring* solution jointly offered by Schreiner MediPharm and AARDEX Group enables pharmaceutical companies to digitally monitor and manage medication intake and to thus cost-efficiently minimize lack of patient compliance.<\/strong>[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text]Smart forms of medicine packaging linked to matching software are at the core of the solution for which Schreiner MediPharm has developed Smart Blister Packs and Smart Kit Boxes for vials or syringes with sensor technology: Whenever a patient extracts a tablet from a cavity or removes a vial from a compartment real-time data are generated such as the time of removal, dose or compartment from which the product is extracted. These data are automatically stored and transmitted to a database via a smartphone app or reader. The matching data platform is provided by AARDEX Group. The leading expert in digital medication adherence solutions offers MEMS\u00ae Adherence Software enabling the visualization and analysis of the data from the dosing history of the Smart Blister or Smart Kit Box. The data may also be shared with defined stakeholders.[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_empty_space height=&#8221;25px&#8221;][\/vc_column][\/vc_row][vc_row][vc_column width=&#8221;1\/2&#8243;][vc_single_image image=&#8221;7115&#8243; img_size=&#8221;full&#8221; css_animation=&#8221;fadeIn&#8221;][\/vc_column][vc_column width=&#8221;1\/2&#8243;][vc_single_image image=&#8221;7109&#8243; img_size=&#8221;full&#8221; css_animation=&#8221;fadeIn&#8221;][\/vc_column][vc_column][vc_column_text]The Smart Blister Packs and Smart Kit Boxes from Schreiner MediPharm equipped with sensor technology provide the basis for digital therapy management.[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_empty_space height=&#8221;25px&#8221;][\/vc_column][\/vc_row][vc_row css=&#8221;.vc_custom_1605111302536{padding-bottom: 3% !important;}&#8221;][vc_column width=&#8221;2\/3&#8243;][vc_empty_space height=&#8221;18px&#8221;][vc_column_text]<\/p>\n<p class=\"Pa4\" style=\"margin-bottom: 11.0pt;\">\u201cOur partnership with AARDEX Group combines Schreiner MediPharm&#8217;s unique smart packaging technology, which can be scaled up via roll-to-roll processes into large commercial volumes, with the necessary intelligence from AARDEX Group. This cooperation will enable us to leverage the full potential of medication adherence in clinical trials and commercial environments. We look forward to supporting our customers with a complete solution and joint consultancy expertise,\u201d says Stefan Wiedemann, Senior Director Strategic Marketing and Business Development at Schreiner MediPharm.<\/p>\n<p>[\/vc_column_text][vc_empty_space height=&#8221;25px&#8221;][\/vc_column][vc_column width=&#8221;1\/3&#8243;][vc_single_image image=&#8221;7113&#8243; img_size=&#8221;full&#8221; add_caption=&#8221;yes&#8221; onclick=&#8221;link_image&#8221; css_animation=&#8221;fadeIn&#8221;][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text]<\/p>\n<p class=\"Pa4\" style=\"margin-bottom: 11.0pt;\">Digital therapy management can decisively optimize drug development by enabling exact compliance with the requirements and dosing regimens of the Clinical Trial Protocols proposed by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). In addition, it is possible to detect structural deficiencies and collect important data about patient behavior that can be used for marketing strategies and other purposes.<\/p>\n<p>[\/vc_column_text][vc_empty_space height=&#8221;15px&#8221;][vc_column_text]<sup><strong>*Medication Adherence Monitoring <\/strong>refers to compliance with the therapy goals set by physicians and patients. For one, it is focused on adherence to action plans and for the other, on disease management between patients and caregivers. The objective is to enhance the personal competency of patients in coping with their disease. Monitoring provides the requisite management tool in this context.<\/sup>[\/vc_column_text][vc_empty_space height=&#8221;15px&#8221;][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text el_class=&#8221;kastenunten&#8221; css=&#8221;.vc_custom_1669739703714{background-color: #e1e7f5 !important;}&#8221;]<strong>AARDEX Group<\/strong><br \/>\nLocated in Belgium, Switzerland and the U.S., AARDEX Group develops and markets digital solutions to measure, analyze and manage medication adherence in clinical trials, research settings, and professional healthcare systems. AARDEX Group is the central actor of a complete ecosystem that combines its MEMS\u00ae Adherence Software with a wide range of smart packages and devices that measure patient adherence to all routes of drug administration. Our vision is to continuously innovate in data-driven medication adherence solutions to enhance digital therapeutics and patient empowerment. <a href=\"http:\/\/www.aardexgroup.com\" target=\"_blank\" rel=\"noopener\"><strong>www.aardexgroup.com<\/strong><\/a>[\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n<\/section>","protected":false},"excerpt":{"rendered":"<p>Lack of knowledge, fear of side effects or forgetfulness: 50 percent of patients involved in clinical trials do not adhere to the prescribed dosage regimen. At the same time, pharmaceutical companies depend on strict compliance with therapy regimes. Otherwise trials may produce distorted outcomes such as insufficient drug efficacy or underestimated frequency of side effects, ultimately resulting in delayed time to market. The Medication Adherence Monitoring* solution jointly offered by Schreiner MediPharm and AARDEX Group enables pharmaceutical companies to digitally monitor and manage medication intake and to thus cost-efficiently minimize lack of patient compliance.<\/p>\n","protected":false},"author":2,"featured_media":7666,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[187],"tags":[223],"class_list":["post-7119","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-schreiner-medipharm-en","tag-medication-adherence-monitoring-en"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Medication Adherence: Digital Therapy Management for Clinical Trials - Schreiner Group Forum<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/forum.schreiner-group.com\/de\/medication-adherence-digitale-therapiesteuerung-fuer-klinische-studien\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Medication Adherence: Digital Therapy Management for Clinical Trials - Schreiner Group Forum\" \/>\n<meta property=\"og:description\" content=\"Lack of knowledge, fear of side effects or forgetfulness: 50 percent of patients involved in clinical trials do not adhere to the prescribed dosage regimen. At the same time, pharmaceutical companies depend on strict compliance with therapy regimes. Otherwise trials may produce distorted outcomes such as insufficient drug efficacy or underestimated frequency of side effects, ultimately resulting in delayed time to market. The Medication Adherence Monitoring* solution jointly offered by Schreiner MediPharm and AARDEX Group enables pharmaceutical companies to digitally monitor and manage medication intake and to thus cost-efficiently minimize lack of patient compliance.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/forum.schreiner-group.com\/de\/medication-adherence-digitale-therapiesteuerung-fuer-klinische-studien\/\" \/>\n<meta property=\"og:site_name\" content=\"Schreiner Group Forum\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-16T08:45:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-11-29T16:35:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/forum.schreiner-group.com\/wp-content\/uploads\/2021\/03\/SMP_Cooperation_AARDEX.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1280\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"markus.liedl@schreiner-group.com\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"markus.liedl@schreiner-group.com\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/forum.schreiner-group.com\/de\/medication-adherence-digitale-therapiesteuerung-fuer-klinische-studien\/\",\"url\":\"https:\/\/forum.schreiner-group.com\/de\/medication-adherence-digitale-therapiesteuerung-fuer-klinische-studien\/\",\"name\":\"Medication Adherence: Digital Therapy Management for Clinical Trials - Schreiner Group Forum\",\"isPartOf\":{\"@id\":\"https:\/\/forum.schreiner-group.com\/de\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/forum.schreiner-group.com\/de\/medication-adherence-digitale-therapiesteuerung-fuer-klinische-studien\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/forum.schreiner-group.com\/de\/medication-adherence-digitale-therapiesteuerung-fuer-klinische-studien\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/forum.schreiner-group.com\/wp-content\/uploads\/2021\/03\/SMP_Cooperation_AARDEX.jpg\",\"datePublished\":\"2021-03-16T08:45:00+00:00\",\"dateModified\":\"2022-11-29T16:35:17+00:00\",\"author\":{\"@id\":\"https:\/\/forum.schreiner-group.com\/de\/#\/schema\/person\/bd0e2515cfe9118ea30379405cb6f7dc\"},\"breadcrumb\":{\"@id\":\"https:\/\/forum.schreiner-group.com\/de\/medication-adherence-digitale-therapiesteuerung-fuer-klinische-studien\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/forum.schreiner-group.com\/de\/medication-adherence-digitale-therapiesteuerung-fuer-klinische-studien\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/forum.schreiner-group.com\/de\/medication-adherence-digitale-therapiesteuerung-fuer-klinische-studien\/#primaryimage\",\"url\":\"https:\/\/forum.schreiner-group.com\/wp-content\/uploads\/2021\/03\/SMP_Cooperation_AARDEX.jpg\",\"contentUrl\":\"https:\/\/forum.schreiner-group.com\/wp-content\/uploads\/2021\/03\/SMP_Cooperation_AARDEX.jpg\",\"width\":1920,\"height\":1280},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/forum.schreiner-group.com\/de\/medication-adherence-digitale-therapiesteuerung-fuer-klinische-studien\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\/\/forum.schreiner-group.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Medication Adherence: Digital Therapy Management for Clinical Trials\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/forum.schreiner-group.com\/de\/#website\",\"url\":\"https:\/\/forum.schreiner-group.com\/de\/\",\"name\":\"Schreiner Group Forum\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/forum.schreiner-group.com\/de\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/forum.schreiner-group.com\/de\/#\/schema\/person\/bd0e2515cfe9118ea30379405cb6f7dc\",\"name\":\"markus.liedl@schreiner-group.com\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/forum.schreiner-group.com\/de\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e83202ed81ba95ae0113c3f2d897918a?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e83202ed81ba95ae0113c3f2d897918a?s=96&d=mm&r=g\",\"caption\":\"markus.liedl@schreiner-group.com\"},\"url\":\"https:\/\/forum.schreiner-group.com\/en\/author\/markus-liedlschreiner-group-de\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Medication Adherence: Digital Therapy Management for Clinical Trials - Schreiner Group Forum","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/forum.schreiner-group.com\/de\/medication-adherence-digitale-therapiesteuerung-fuer-klinische-studien\/","og_locale":"en_US","og_type":"article","og_title":"Medication Adherence: Digital Therapy Management for Clinical Trials - Schreiner Group Forum","og_description":"Lack of knowledge, fear of side effects or forgetfulness: 50 percent of patients involved in clinical trials do not adhere to the prescribed dosage regimen. At the same time, pharmaceutical companies depend on strict compliance with therapy regimes. Otherwise trials may produce distorted outcomes such as insufficient drug efficacy or underestimated frequency of side effects, ultimately resulting in delayed time to market. The Medication Adherence Monitoring* solution jointly offered by Schreiner MediPharm and AARDEX Group enables pharmaceutical companies to digitally monitor and manage medication intake and to thus cost-efficiently minimize lack of patient compliance.","og_url":"https:\/\/forum.schreiner-group.com\/de\/medication-adherence-digitale-therapiesteuerung-fuer-klinische-studien\/","og_site_name":"Schreiner Group Forum","article_published_time":"2021-03-16T08:45:00+00:00","article_modified_time":"2022-11-29T16:35:17+00:00","og_image":[{"width":1920,"height":1280,"url":"https:\/\/forum.schreiner-group.com\/wp-content\/uploads\/2021\/03\/SMP_Cooperation_AARDEX.jpg","type":"image\/jpeg"}],"author":"markus.liedl@schreiner-group.com","twitter_card":"summary_large_image","twitter_misc":{"Written by":"markus.liedl@schreiner-group.com","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/forum.schreiner-group.com\/de\/medication-adherence-digitale-therapiesteuerung-fuer-klinische-studien\/","url":"https:\/\/forum.schreiner-group.com\/de\/medication-adherence-digitale-therapiesteuerung-fuer-klinische-studien\/","name":"Medication Adherence: Digital Therapy Management for Clinical Trials - Schreiner Group Forum","isPartOf":{"@id":"https:\/\/forum.schreiner-group.com\/de\/#website"},"primaryImageOfPage":{"@id":"https:\/\/forum.schreiner-group.com\/de\/medication-adherence-digitale-therapiesteuerung-fuer-klinische-studien\/#primaryimage"},"image":{"@id":"https:\/\/forum.schreiner-group.com\/de\/medication-adherence-digitale-therapiesteuerung-fuer-klinische-studien\/#primaryimage"},"thumbnailUrl":"https:\/\/forum.schreiner-group.com\/wp-content\/uploads\/2021\/03\/SMP_Cooperation_AARDEX.jpg","datePublished":"2021-03-16T08:45:00+00:00","dateModified":"2022-11-29T16:35:17+00:00","author":{"@id":"https:\/\/forum.schreiner-group.com\/de\/#\/schema\/person\/bd0e2515cfe9118ea30379405cb6f7dc"},"breadcrumb":{"@id":"https:\/\/forum.schreiner-group.com\/de\/medication-adherence-digitale-therapiesteuerung-fuer-klinische-studien\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/forum.schreiner-group.com\/de\/medication-adherence-digitale-therapiesteuerung-fuer-klinische-studien\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/forum.schreiner-group.com\/de\/medication-adherence-digitale-therapiesteuerung-fuer-klinische-studien\/#primaryimage","url":"https:\/\/forum.schreiner-group.com\/wp-content\/uploads\/2021\/03\/SMP_Cooperation_AARDEX.jpg","contentUrl":"https:\/\/forum.schreiner-group.com\/wp-content\/uploads\/2021\/03\/SMP_Cooperation_AARDEX.jpg","width":1920,"height":1280},{"@type":"BreadcrumbList","@id":"https:\/\/forum.schreiner-group.com\/de\/medication-adherence-digitale-therapiesteuerung-fuer-klinische-studien\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/forum.schreiner-group.com\/en\/"},{"@type":"ListItem","position":2,"name":"Medication Adherence: Digital Therapy Management for Clinical Trials"}]},{"@type":"WebSite","@id":"https:\/\/forum.schreiner-group.com\/de\/#website","url":"https:\/\/forum.schreiner-group.com\/de\/","name":"Schreiner Group Forum","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/forum.schreiner-group.com\/de\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/forum.schreiner-group.com\/de\/#\/schema\/person\/bd0e2515cfe9118ea30379405cb6f7dc","name":"markus.liedl@schreiner-group.com","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/forum.schreiner-group.com\/de\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/e83202ed81ba95ae0113c3f2d897918a?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e83202ed81ba95ae0113c3f2d897918a?s=96&d=mm&r=g","caption":"markus.liedl@schreiner-group.com"},"url":"https:\/\/forum.schreiner-group.com\/en\/author\/markus-liedlschreiner-group-de\/"}]}},"_links":{"self":[{"href":"https:\/\/forum.schreiner-group.com\/en\/wp-json\/wp\/v2\/posts\/7119","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/forum.schreiner-group.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/forum.schreiner-group.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/forum.schreiner-group.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/forum.schreiner-group.com\/en\/wp-json\/wp\/v2\/comments?post=7119"}],"version-history":[{"count":16,"href":"https:\/\/forum.schreiner-group.com\/en\/wp-json\/wp\/v2\/posts\/7119\/revisions"}],"predecessor-version":[{"id":11106,"href":"https:\/\/forum.schreiner-group.com\/en\/wp-json\/wp\/v2\/posts\/7119\/revisions\/11106"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/forum.schreiner-group.com\/en\/wp-json\/wp\/v2\/media\/7666"}],"wp:attachment":[{"href":"https:\/\/forum.schreiner-group.com\/en\/wp-json\/wp\/v2\/media?parent=7119"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/forum.schreiner-group.com\/en\/wp-json\/wp\/v2\/categories?post=7119"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/forum.schreiner-group.com\/en\/wp-json\/wp\/v2\/tags?post=7119"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}